Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned?
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Next to cancer, Alzheimer’s disease (AD) and dementia is probably the most worrying health problem facing the Western world today. A large number of clinical trials have failed to show any benefit of the tested drugs in stabilizing or reversing the steady decline in cognitive function that is suffered by dementia patients. Although the pathological features of AD consisting of beta-amyloid plaques and tau tangles are well established, considerable debate exists concerning the genetic or lifestyle factors that predispose individuals to developing dementia. Photobiomodulation (PBM) describes the therapeutic use of red or near-infrared light to stimulate healing, relieve pain and inflammation, and prevent tissue from dying. In recent years PBM has been applied for a diverse range of brain disorders, frequently applied in a non-invasive manner by shining light on the head (transcranial PBM). The present review discusses the mechanisms of action of tPBM in the brain, and summarizes studies that have used tPBM to treat animal models of AD. The results of a limited number of clinical trials that have used tPBM to treat patients with AD and dementia are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 2×
“[134] used a different transgenic mouse model, 5XFAD transgenic male mice (Tg6799) that co-overexpress familial AD (FAD) mutant forms of human APP (the Swedish mutation, K670N/M671L; the Florida mutation, I716V; and the London mutation, V717I) and PS1 (M146L/L286V) trans-genes, under transcriptional control of the neu…”
Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., & Jones, E. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61349-9 · Cited by 2,336
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Tang, Y., & Le, W. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9070-5 · Cited by 2,190
Microglial M1/M2 polarization and metabolic states
Orihuela, R., McPherson, C. A., & Harry, G. J. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13139 · Cited by 2,070 · cited 1×
“Increasing evidence suggests a role of metabolic reprogramming in the regulation of the innate inflammatory response [105].”
BackgroundDominy, S. S., Lynch, C., Ermini, F., Benedyk, M., Marczyk, A., Konradi, A., Nguyen, M., Haditsch, U., Raha, D., Griffin, C., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau3333 · Cited by 1,966 · cited 1×
“Bacteria themselves, such as Porphyromonas gingivalis, have been found in AD brains [55].”
BackgroundMoreno-Jiménez, E. P., Flor-García, M., Terreros-Roncal, J., Rábano, A., Cafini, F., Pallas-Bazarra, N., Ávila, J., & Llorens-Martín, M. (2019) · Nature Medicine · doi:10.1038/s41591-019-0375-9 · Cited by 1,577 · cited 1×
“A recent report [119] showed that there was a sharp drop in hippocampal neurogenesis in subjects with AD, and this reduction increased along with disease progession.”
BackgroundGamma frequency entrainment attenuates amyloid load and modifies microglia
Iaccarino, H. F., Singer, A. C., Martorell, A. J., Rudenko, A., Gao, F., Gillingham, T. Z., Mathys, H., Seo, J., Kritskiy, O., Abdurrob, F., et al. (2016) · Nature · doi:10.1038/nature20587 · Cited by 1,328 · cited 1×
“, working at MIT, reported that 40 Hz pulsed blue light could reduce the load of amyloid-β (Aβ)1-40 and Aβ 1-42 peptides and lessen the amyloid plaque burden in the visual cortex of the brain in a mouse model of AD [139].”
BackgroundCerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243 · cited 1×
“Disorders of CBF, neurovascular dysfunction, and lower brain oxygenation have been proposed to an important feature of AD [70].”
BackgroundThe Gut Microbiota and Alzheimer’s Disease
Jiang, C., Li, G., Huang, P., Liu, Z., & Zhao, B. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161141 · Cited by 852
The cryptochromes: blue light photoreceptors in plants and animals
Chaves, I., Pokorny, R., Byrdin, M., Hoang, N., Ritz, T., Brettel, K., Essen, L.-O., van der Horst, G. T. J., Batschauer, A., & Ahmad, M. (2011) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-042110-103759 · Cited by 845 · cited 1×
“Cryptochromes are a special sub-class of flavoproteins that act as blue–light receptors in plants, animals and even humans [19].”
BackgroundReconsideration of Amyloid Hypothesis and Tau Hypothesis in Alzheimer's Disease
Kametani, F., & Hasegawa, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00025 · Cited by 836
Brain-Gut-Microbiota Axis in Alzheimer’s Disease
Kowalski, K., & Mulak, A. (2019) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm18087 · Cited by 826 · cited 1×
“The bacteria themselves may secrete bacterial amyloid that may trigger cross-seeding of amyloid plaques, or else the bacteria may over-stimulate the innate immune response [54].”
BackgroundMulti-sensory Gamma Stimulation Ameliorates Alzheimer’s-Associated Pathology and Improves Cognition
Martorell, A. J., Paulson, A. L., Suk, H.-J., Abdurrob, F., Drummond, G. T., Guan, W., Young, J. Z., Kim, D. N.-W., Kritskiy, O., Barker, S. J., et al. (2019) · Cell · doi:10.1016/j.cell.2019.02.014 · Cited by 798 · cited 1×
“This group went on to test a combination of 40 Hz blue light with 40 Hz auditory stimulation to produce “gamma entrainment using sensory stimulus” (GENUS) [141].”
MethodOxidative stress in Alzheimer’s disease
Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1423-y · Cited by 797 · cited 1×
“Oxidative stress causes Aβ deposition, tau hyperphosphorylation, and the subsequent loss of synapses and neurons [96].”
BackgroundThe Alzheimer’s disease mitochondrial cascade hypothesis: progress and perspectives
Swerdlow, R. H., Burns, J. M., & Khan, S. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.010 · Cited by 786 · cited 1×
“This has been reported for neurological conditions such as major depressive disorder [61], traumatic brain injury [62], Parkinson’s disease [63], and for AD [64].”
BackgroundVascular dysfunction—The disregarded partner of Alzheimer's disease
Sweeney, M. D., Montagne, A., Sagare, A. P., Nation, D. A., Schneider, L. S., Chui, H. C., Harrington, M. G., Pa, J., Law, M., Wang, D. J. J., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.222 · Cited by 711 · cited 1×
“Vascular dysfunction is often described as causing vascular dementia, but there is increasing evidence that it plays a role in AD as well [47].”
BackgroundThe Sedoheptulose Kinase CARKL Directs Macrophage Polarization through Control of Glucose Metabolism
Haschemi, A., Kosma, P., Gille, L., Evans, C. R., Burant, C. F., Starkl, P., Knapp, B., Haas, R., Schmid, J. A., Jandl, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.023 · Cited by 635 · cited 1×
“Studies have demonstrated that the M1 phenotype is often accompanied by a shift from oxidative phosphorylation to aerobic glycolysis for energy production [106].”
BackgroundAstrocyte-derived ATP modulates depressive-like behaviors
Cao, X., Li, L.-P., Wang, Q., Wu, Q., Hu, H.-H., Zhang, M., Fang, Y.-Y., Zhang, J., Li, S.-J., Xiong, W.-C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3162 · Cited by 615
Oxidative stress hypothesis in Alzheimer’s disease: a reappraisal
Praticò, D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.09.001 · Cited by 606 · cited 1×
“Oxidative stress has been implicated in the pathogenesis of AD [50].”
BackgroundSarandol, A., Sarandol, E., Eker, S. S., Erdinc, S., Vatansever, E., & Kirli, S. (2007) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.829 · Cited by 486
Dendritic structural plasticity and neuropsychiatric disease
Forrest, M. P., Parnell, E., & Penzes, P. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2018.16 · Cited by 464 · cited 1×
“If it can be conclusively shown that tPBM stimulates neuroplasticity and synaptogenesis in humans as well as mice, then this opens the door to a wide range of clinical applications [126].”
BackgroundRefining deep brain stimulation to emulate optogenetic treatment of synaptic pathology
Creed, M., Pascoli, V. J., & Lüscher, C. (2015) · Science · doi:10.1126/science.1260776 · Cited by 280
Bergmann, O., Spalding, K. L., & Frisén, J. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018994 · Cited by 256
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-802395-2.00025-0 · Cited by 225
A distinct population of microglia supports adult neurogenesis in the subventricular zone
Ribeiro Xavier, A. L., Kress, B. T., Goldman, S. A., Lacerda de Menezes, J. R., & Nedergaard, M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1217-15.2015 · Cited by 225 · cited 1×
“The most well accepted neurogenic niches are the sub-granular layer of the dentate gyrus of the hippocampus [114], and the subventricular zone (SVZ) of the lateral ventricles [115].”
BackgroundImproving executive function using transcranial infrared laser stimulation
Blanco, N. J., Maddox, W. T., & Gonzalez‐Lima, F. (2017) · Journal of Neuropsychology · doi:10.1111/jnp.12074 · Cited by 179 · cited 1×
“How then can we explain that PBM can have powerful effects on the brain at wavelengths as long as 1064 nm [27,28]? One answer may lie in the concept of ‘nanostructured water’ or ‘interfacial water’ elaborated by Pollack [29–31].”
BackgroundPrinciples of Neuroplasticity-Based Rehabilitation
Nahum, M., Lee, H., & Merzenich, M. M. (2013) · Progress in Brain Research · doi:10.1016/b978-0-444-63327-9.00009-6 · Cited by 158 · cited 6×
“Keywords: photobiomodulation; Alzheimer’s disease; dementia; mechanisms of action; animal models; clinical trials”
BackgroundInfluentialPericapillary Haem-Rich Deposits: Evidence for Microhaemorrhages in Aging Human Cerebral Cortex
Cullen, K. M., Kócsi, Z., & Stone, J. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600155 · Cited by 137 · cited 1×
“A related hypothesis concerns the influence of vascular dysfunction and micro-hemorrhages [46].”
BackgroundNoninvasive 40-hz light flicker to recruit microglia and reduce amyloid beta load
Singer, A. C., Martorell, A. J., Douglas, J. M., Abdurrob, F., Attokaren, M. K., Tipton, J., Mathys, H., Adaikkan, C., & Tsai, L.-H. (2018) · Nature Protocols · doi:10.1038/s41596-018-0021-x · Cited by 127
A Mild Traumatic Brain Injury in Mice Produces Lasting Deficits in Brain Metabolism
Lyons, D. N., Vekaria, H., Macheda, T., Bakshi, V., Powell, D. K., Gold, B. T., Lin, A.-L., Sullivan, P. G., & Bachstetter, A. D. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5663 · Cited by 55 · cited 1×
“This has been reported for neurological conditions such as major depressive disorder [61], traumatic brain injury [62], Parkinson’s disease [63], and for AD [64].”
Background
Cited by
Nguyen, P. H., Ramamoorthy, A., Sahoo, B. R., Zheng, J., Faller, P., Straub, J. E., Dominguez, L., Shea, J.-E., Dokholyan, N. V., De Simone, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01122 · Cited by 678
Microglia and Astrocytes in Alzheimer’s Disease: Significance and Summary of Recent Advances
Deng, Q., Wu, C., Parker, E., Liu, T. C.-Y., Duan, R., & Yang, L. (2023) · Aging and disease · doi:10.14336/ad.2023.0907 · Cited by 102
“Photobiomodulation (PBM) is a potential therapeutic strategy for AD, which utilizes low-power laser and near-infrared spectra to activate beneficial biological responses in cells [282, 283].”
BackgroundAβ-binding with alcohol dehydrogenase drives Alzheimer's disease pathogenesis: A review
Ye, Z., Liu, Y., Jin, X., Wu, Y., Zhao, H., Gao, T., Deng, Q., Cheng, J., Lin, J., & Tong, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.130580 · Cited by 23
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease
Zhou, C., Zeng, F., Yang, H., Liang, Z., Xu, G., Li, X., Liu, X., & Yang, J. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06690-1 · Cited by 14
“…phototherapy has also shown enormous potential in the treatment of AD, based on photothermal transfer agents (PTAs) and photo-sensitizers (PSs) that trigger photochemical reactions to produce reactive oxygen species (ROS) or thermal effects to reduce the accumulation of Aβ for treating AD [40].”
Metadata
- Authors
- Hamblin, M.
- Venue
- Photonics
- Publisher
- MDPI AG
- Published
- 2019-07-04
- Volume
- 6
- Issue
- 3
- Pages
- 77
- ISSN
- 2304-6732 (ISSN-L)
- OpenAlex
- W2954913294
- Cited by
- 135
- References
- 30
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.